Joaquim Gama-Rodrigues
Overview
Explore the profile of Joaquim Gama-Rodrigues including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
2302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jimenez L, Perez R, Sao Juliao G, Vailati B, Fernandez L, Gama-Rodrigues J, et al.
Dis Colon Rectum
. 2019 Dec;
63(3):300-309.
PMID: 31842156
Background: Patients with rectal cancer may undergo neoadjuvant chemoradiation even in early stages in an attempt to achieve complete clinical response and undergo organ preservation. However, prediction of tumor response...
2.
Habr-Gama A, Sao Juliao G, Fernandez L, Vailati B, Andrade A, Araujo S, et al.
Dis Colon Rectum
. 2019 Jun;
62(7):802-808.
PMID: 31188180
Background: Patients with rectal cancer who achieve complete clinical response after neoadjuvant chemoradiation have been managed by organ-preserving strategies and acceptable long-term outcomes. Controversy still exists regarding optimal timing for...
3.
Habr-Gama A, Sao Juliao G, Vailati B, Fernandez L, Ortega C, Figueiredo N, et al.
Dis Colon Rectum
. 2019 Mar;
62(6):675-683.
PMID: 30870223
Background: Select patients with complete clinical response to chemoradiation have been managed without radical surgery. The presence of radiologic evidence of nodal metastases at baseline could be a risk factor...
4.
Moron R, Jacob C, Bresciani C, Simoes K, Alves V, Irya K, et al.
Mol Clin Oncol
. 2018 Feb;
8(3):477-482.
PMID: 29468062
The aim of the present study was to determine the clinical significance of p53 and p21 p21, p27 and p16 expression in cases of early gastric cancer. A total of...
5.
Sao Juliao G, Habr-Gama A, Vailati B, Aguilar P, Sabbaga J, Araujo S, et al.
Eur J Surg Oncol
. 2017 Dec;
44(1):93-99.
PMID: 29217398
Methods: Patients with distal and non-metastatic T3 rectal cancer managed by nCRT were retrospectively reviewed. Patients undergoing standard CRT (50.4 Gy and 2 cycles of 5FU-based chemotherapy) were compared to...
6.
Habr-Gama A, Sao Juliao G, Gama-Rodrigues J, Vailati B, Ortega C, Fernandez L, et al.
Dis Colon Rectum
. 2017 May;
60(6):586-594.
PMID: 28481852
Background: Selected patients with rectal cancer and complete clinical response after neoadjuvant chemoradiation have been managed nonoperatively with acceptable outcomes. However, ≈20% of these patients will develop early tumor regrowth....
7.
Habr-Gama A, Sao Juliao G, Mattacheo A, Campos-Lobato L, Aleman E, Vailati B, et al.
World J Surg
. 2017 Mar;
41(8):2160-2167.
PMID: 28265736
Background: Abdominal perineal excision (APE) has been associated with a high risk of positive circumferential resection margin (CRM+) and local recurrence rates in the treatment of rectal cancer. An alternative...
8.
Perez R, Habr-Gama A, Sao Juliao G, Vailati B, Fernandez L, Gama-Rodrigues J, et al.
Dis Colon Rectum
. 2016 Aug;
59(9):895-7.
PMID: 27505119
No abstract available.
9.
Bettoni F, Masotti C, Habr-Gama A, Correa B, Gama-Rodrigues J, Vianna M, et al.
Ann Surg
. 2016 Aug;
265(1):e4-e6.
PMID: 27479130
Objective: Demonstrate intratumoral genetic heterogeneity in rectal cancer. Background: Several clinical management decisions in rectal cancer may be influenced by pretreatment biopsy information. However, in the setting of significant intratumoral...
10.
Habr-Gama A, Lynn P, Jorge J, Sao Juliao G, Proscurshim I, Gama-Rodrigues J, et al.
Dis Colon Rectum
. 2016 Mar;
59(4):264-9.
PMID: 26953984
Background: Organ-preserving strategies have been considered for patients with distal rectal cancer and complete or near-complete response to neoadjuvant chemoradiation to avoid the functional consequences of radical surgery. Transanal endoscopic...